Results

Total Results: 23 records

Showing results for "adverse".

1. June 2021 CDS Connect Work Group Slides (pdf file)
   cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Slides_0.pdf
   January 01, 2021 - 14.3% of inpatients ► 231,000 US emergency department visits • Hospital admissions associated with an adverse … Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions. … newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse

2. Implementation Guide: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease (CVD): An Electronic Clinical Quality Measure (eCQM)-derived CDS (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
   January 01, 2024 - Patient has known adverse reactions to statins. ii. … Patient is likely to have adverse reactions to statins. iii. … respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse … The CQL value set and logic differ in that they contain adverse effects, allergies, and intolerances

3. CDS Connect Implementation Guide Draft (doc file)
   cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
   October 01, 2017 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse … DENOMINATOR EXCEPTIONS: Patients with adverse effect, allergy, or intolerance to statin medication.

4. Deprescriptions | CDS Connect
   cds.ahrq.gov/taxonomy/term/4491
   July 05, 2022 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

5. Warfarin-Nsaids Mdia Implementation Guide (doc file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
   November 11, 2019 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

6. Risk Assessment | CDS Connect
   cds.ahrq.gov/taxonomy/term/2136
   May 31, 2022 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

7. CDS Connect Work Group June 2021 Summary (pdf file)
   cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Summary_0.pdf
   January 01, 2021 - weighs the risk factors to produce a risk array that visually represents the estimated risk of an adverse

8. CDS Connect Implementation Guide Draft (doc file)
   cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
   October 01, 2017 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

9. Warfarin-Antidepressants Mdia Implementation Guide (doc file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
   August 29, 2020 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

10. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2024 - Patient has known adverse reactions to statins. b. … Patient is likely to have adverse reactions to statins. c. … implement CQL code, along https://github.com/AHRQ-CDS/CQL-Testing-Framework 15 with any potential adverse … Testing should also ensure that implementation of the artifact has no adverse effect on the processing

11. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

12. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
    February 01, 2018 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

13. Implementation Guide: Prediabetes and Type 2 Diabetes: Part Two, Counseling (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
    January 01, 2024 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

14. Implementation Guide: Prediabetes and Type 2 Diabetes: Part One, Screening (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
    January 01, 2024 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

15. Implementation Guide: Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Cardiovascular Risk Factors (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
    January 01, 2024 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … Additionally, testing should be conducted to ensure that implementation of the artifact has no adverse

16. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - IT products to understand their capacity to implement CQL code, along with any potential 19 adverse … Testing should also ensure that implementation of the artifact has no adverse effect on the processing

17. Implementation Guide: Factors to Consider in Managing Chronic Pain (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
    January 01, 2024 - respective health IT products to understand their readiness to implement CQL code and any potential adverse … testing by the implementer should be conducted to ensure that implementation of the artifact has no adverse

18. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
    October 01, 2017 - the context of other considerations, including patient preferences for taking medications, potential adverse

19. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - respective health IT products to understand their capacity to implement CQL code, along with any potential adverse … Testing should also ensure that implementation of the artifact has no adverse effect on the processing

20. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making (2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
    April 01, 2021 - the context of other considerations, including patient preferences for taking medications, potential adverse